Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
BJU International
|
October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells
Laura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Nature Communications
|
June 8, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer
Zifeng Wang, Scott L Townley, Songqi Zhang, et al.
Molecular & Cellular Proteomics : MCP
|
May 8, 2019
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment
Elizabeth V Nguyen, Brooke A Pereira, Mitchell G Lawrence, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Nature Reviews. Urology
|
January 17, 2023
The future of patient-derived xenografts in prostate cancer research
Mitchell G Lawrence, Renea A Taylor, Georgia B Cuffe, et al.
Biomaterials
|
April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer
Ashlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
The Prostate
|
June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer
Laura H Porter, Mitchell G Lawrence, Hong Wang, et al.
The EMBO Journal
|
September 27, 2019
Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression
Julie Lorent, Eric P Kusnadi, Vincent van Hoef, et al.
British Journal of Cancer
|
August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
British Journal of Cancer
|
October 25, 2024
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
BJU International
|
October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells
Laura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Nature Communications
|
June 8, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer
Zifeng Wang, Scott L Townley, Songqi Zhang, et al.
Molecular & Cellular Proteomics : MCP
|
May 8, 2019
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment
Elizabeth V Nguyen, Brooke A Pereira, Mitchell G Lawrence, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition
Mitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Nature Reviews. Urology
|
January 17, 2023
The future of patient-derived xenografts in prostate cancer research
Mitchell G Lawrence, Renea A Taylor, Georgia B Cuffe, et al.
Biomaterials
|
April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer
Ashlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
The Prostate
|
June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer
Laura H Porter, Mitchell G Lawrence, Hong Wang, et al.
The EMBO Journal
|
September 27, 2019
Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression
Julie Lorent, Eric P Kusnadi, Vincent van Hoef, et al.
British Journal of Cancer
|
August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
British Journal of Cancer
|
October 25, 2024
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Page
of 6